A phase I study of sequential versus concurrent interleukin-3 and granulocyte-macrophage colony-stimulating factor in advanced breast cancer patients treated with FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy

J. A. O'Shaughnessy, D. J. Venzon, M. Gossard, M. H. Noone, A. Denicoff, A. Tolcher, D. Danforth, J. Jacobson, P. Keegan, L. Miller, C. Chow, B. Goldspiel, K. H. Cowan

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I study of sequential versus concurrent interleukin-3 and granulocyte-macrophage colony-stimulating factor in advanced breast cancer patients treated with FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds